ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002

RFA On Pathology Training Released

February 1, 1980

NCI AIDS Malignancy Bank Accepts Requests; RFA Available

December 1, 1995

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Training Grants Are Back; IGMS Implements New Program, With Awards To Be Made In June

January 24, 1975